Cargando…

Synthesis of composite magnetic nanoparticles Fe(3)O(4) with alendronate for osteoporosis treatment

Osteoporosis is a result of imbalance between bone formation by osteoblasts and resorption by osteoclasts (OCs). In the present study, we investigated the potential of limiting the aggravation of osteoporosis by reducing the activity of OCs through thermolysis. The proposed method is to synthesize b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ming-Song, Su, Chao-Ming, Yeh, Jih-Chao, Wu, Pei-Ru, Tsai, Tien-Yao, Lou, Shyh-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028093/ https://www.ncbi.nlm.nih.gov/pubmed/27695319 http://dx.doi.org/10.2147/IJN.S112415

Ejemplares similares

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials
por: Wang, Ya-Kang, et al.
Publicado: (2018)

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
por: Li, Mei, et al.
Publicado: (2022)

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
por: Bone, Henry G, et al.
Publicado: (2018)

Co-Doped NdFeO(3) Nanoparticles: Synthesis, Optical, and Magnetic Properties Study
por: Nguyen, Tien Anh, et al.
Publicado: (2021)

Exosome purification based on PEG-coated Fe(3)O(4) nanoparticles
por: Chang, Ming, et al.
Publicado: (2018)

Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis
por: Qin, Ling, et al.
Publicado: (2007)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
por: Jain, Sumit Kumar, et al.
Publicado: (2011)

Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report
por: Widjaja, David, et al.
Publicado: (2011)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
por: Ahn, Guk Young, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model
por: Muraleva, Natalya A., et al.
Publicado: (2012)

A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
por: Piriyakhuntorn, Pokpong, et al.
Publicado: (2023)

Ultrafine metallic Fe nanoparticles: synthesis, structure and magnetism
por: Margeat, Olivier, et al.
Publicado: (2010)

Thrombolysis Enhancing by Magnetic Manipulation of Fe(3)O(4) Nanoparticles
por: Li, Qian, et al.
Publicado: (2018)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Iwamoto, Jun, et al.
Publicado: (2008)

Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?
por: Kolios, Leila, et al.
Publicado: (2009)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
por: Ebadi Fard Azar, Amir Ali, et al.
Publicado: (2017)

ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020)

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend
por: Greenspan, Susan L., et al.
Publicado: (2020)

Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus
por: Xiong, Zhencheng, et al.
Publicado: (2022)

Immobilization of ω-transaminase by magnetic PVA-Fe(3)O(4) nanoparticles
por: Jia, Honghua, et al.
Publicado: (2016)

Sequential treatment of teriparatide and alendronate versus alendronate alone for elevation of bone mineral density and prevention of refracture after percutaneous vertebroplasty in osteoporosis: a prospective study
por: Yang, Dazhi, et al.
Publicado: (2023)

Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo
por: Li, Yuntao, et al.
Publicado: (2011)

Antibacterial Effects of Magnetically-Controlled Ag/Fe(3)O(4) Nanoparticles
por: Chang, Ming, et al.
Publicado: (2018)

The Synthesis Methodology and Characterization of Nanogold-Coated Fe(3)O(4) Magnetic Nanoparticles
por: Kędzierska, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kf1fkabpee8p1qlimg9ap2mabq